Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/1239
Title: Community-based intervention to improve cardiometabolic targets in patients with stroke: a randomized controlled trial.
Epworth Authors: Gerraty, Richard
Other Authors: Olaiya, Muideen
Cadilhac, Dominique
Kim, Joosup
Nelson, Mark
Srikanth, Velandai
Bladin, Christopher
Fitzgerald, Sharyn
Phan, Thanh
Frayne, Judith
Thrift, Amanda
Keywords: Cardiovascular Disease
Cardiometabolic
Transient Ischemic Attack
TIA
Secondary Prevention
Guidelines
Risk Factors
Goals
Stroke
American Heart Association
Treatment Outcomes
Interventions
Lipoprotein Cholesterol
Medication Adherence
Lifestyle Habits
Functional Ability
Diabetes Mellitus
Behavioral Change
Cardiometabolic Targets
Neurosciences Clinical Institute, Epworth HealthCare, Victoria, Australia
Department of Medicine, Epworth Healthcare, Australia.
Issue Date: Sep-2017
Publisher: Lippincott Williams & Wilkins for American Heart Association
Citation: Stroke. 2017 Sep;48(9):2504-2510
Abstract: BACKGROUND AND PURPOSE: Many guidelines for secondary prevention of stroke focus on controlling cardiometabolic risk factors. We investigated the effectiveness of a management program for attaining cardiometabolic targets in survivors of stroke/transient ischemic attack. METHODS: Randomized controlled trial of survivors of stroke/transient ischemic attack aged ≥18 years. General practices were randomized to usual care (control) or an intervention comprising specialist review of care plans and nurse education in addition to usual care. The outcome is attainment of pre-defined cardiometabolic targets based on Australian guidelines. Multivariable regression was undertaken to determine efficacy and identify factors associated with attaining targets. RESULTS: Overall, 283 subjects were randomized to the intervention and 280 to controls. Although we found no between-group difference in overall cardiometabolic targets achieved at 12 months, the intervention group more often achieved control of low-density lipoprotein cholesterol (odds ratio, 1.97; 95% confidence interval, 1.18-3.29) than controls. At 24 months, no between-group differences were observed. Medication adherence was ≥80% at follow-up, but uptake of lifestyle/behavioral habits was poor. Older age, being male, being married/living with partner, and having greater functional ability or a history of diabetes mellitus were associated with attaining targets. CONCLUSIONS: The intervention in this largely negative trial only had a detectable effect on attaining target for lipids but not for other factors at 12 months or any factor at 24 months. This limited effect may be attributable to inadequate uptake of behavioral/lifestyle interventions, highlighting the need for new or better approaches to achieve meaningful behavioral change.
URI: http://hdl.handle.net/11434/1239
DOI: 10.1161/STROKEAHA.117.017499
PubMed URL: https://www.ncbi.nlm.nih.gov/pubmed/28754834
ISSN: 0039-2499
1524-4628
Journal Title: Stroke
Type: Journal Article
Affiliated Organisations: Stroke and Ageing Research, Department of Medicine, School of Clinical Sciences, Monash Health
Department of Epidemiology and Preventive Medicine, Monash University, Clayton, Victoria, Australia.
Stroke Division, Florey Institute of Neuroscience and Mental Health, Heidelberg, Victoria, Australia.
Menzies Institute for Medical Research, Hobart, Tasmania, Australia.
Department of Neurosciences, Box Hill Hospital, Victoria, Australia.
Department of Neurology, Alfred Hospital, Melbourne, Victoria, Australia.
Type of Clinical Study or Trial: Randomized Controlled Clinical Trial
Appears in Collections:Neurosciences
Cardiac Sciences

Files in This Item:
There are no files associated with this item.


Items in EKB are protected by copyright, with all rights reserved, unless otherwise indicated.